160 related articles for article (PubMed ID: 699677)
1. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
Dixon DM; Wagner GE; Shadomy S; Shadomy HJ
Chemotherapy; 1978; 24(6):364-7. PubMed ID: 699677
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.
Dixon D; Shadomy S; Shadomy HJ; Espinel-Ingroff A; Kerkering TM
J Infect Dis; 1978 Aug; 138(2):245-8. PubMed ID: 681800
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies with ambruticin, a new antifungal antibiotic.
Shadomy S; Dixon DM; Espinel-Ingroff A; Wagner GE; Yu HP; Shadomy HJ
Antimicrob Agents Chemother; 1978 Jul; 14(1):99-104. PubMed ID: 686712
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of clotrimazole (Bay b 5097).
Shadomy S
Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
Gebhart RJ; Espinel-Ingroff A; Shadomy S
Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
[TBL] [Abstract][Full Text] [Related]
7. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus.
Martinez J; Torres JM; Arteaga F; Foz-Tena A
Mycopathologia; 1978 Nov; 64(3):147-51. PubMed ID: 104180
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
Uchida K; Hosaka J; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.
Okeke CN; Gugnani HC
Mycopathologia; 1987 Sep; 99(3):175-81. PubMed ID: 3657909
[TBL] [Abstract][Full Text] [Related]
10. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Odds FC
Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
González GM; Fothergill AW; Sutton DA; Rinaldi MG; Loebenberg D
Med Mycol; 2005 May; 43(3):281-4. PubMed ID: 16010855
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
Eng RH; Person A; Mangura C; Chmel H; Corrado M
Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis.
Hennequin C; Benailly N; Silly C; Sorin M; Scheinmann P; Lenoir G; Gaillard JL; Berche P
Antimicrob Agents Chemother; 1997 Sep; 41(9):2064-6. PubMed ID: 9303420
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole.
Cosgrove RF; Beezer AE; Miles RJ
J Infect Dis; 1978 Nov; 138(5):681-5. PubMed ID: 361901
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
Yamaguchi H; Hiratani T; Plempel M
Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
Corrado ML; Kramer M; Cummings M; Eng RH
Sabouraudia; 1982 Jun; 20(2):109-13. PubMed ID: 6287653
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Maeda J; Koga H; Yuasa K; Neki D; Nanjoh Y; Inagaki K; Reangchainam S; Kampirapap K; Makimura K; Harada K; Tsuboi R
Med Mycol; 2020 Jul; 58(5):703-706. PubMed ID: 31758690
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
